 Revance Therapeutics, Inc. NASDAQ:RVNC Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Jessica Serra - Head-Investor Relations and ESG Mark Foley - Chief Executive Officer Toby Schilke - Chief Financial Officer Conference Call Participants Operator Welcome to the Revance Therapeutics Second Quarter 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. 